The Impact of a 48-hour Fast with or Without Exercise on Immune Cell Metabolism and Glycemic Control in Healthy Active Adults
FASTEX
1 other identifier
interventional
15
1 country
1
Brief Summary
Many individuals engage in fasting for its purported health benefits but the effects of fasting on immune cell and whole body metabolism are not well understood in humans. Moreover, how exercising during a prolonged fast impacts immunometabolic outcomes is unclear. This study will determine how a 2 day fast - performed with or without daily exercise - impacts immune cell bioenergetics, immune cell function, and whole-body glycemic control in healthy active individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 8, 2024
CompletedFirst Posted
Study publicly available on registry
December 17, 2024
CompletedStudy Start
First participant enrolled
January 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedMarch 7, 2025
March 1, 2025
7 months
October 8, 2024
March 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Monocyte mitochondrial respiration
Mitochondrial respiration will be measured in primary human monocytes using high resolution respirometry before and after a 48-hour fast performed with or without exercise.
Baseline and 48 hours
Secondary Outcomes (11)
Alteration in immune cell functions
Baseline and 48 hours
Change in glucose tolerance
Baseline, after 48 hours of fasting, and 24 hours after breaking the fast in free-living condition)
Blood pressure
Baseline, 24 hours into the fast, and at the end of the fast (48 hours)
Rate and level of ketosis
Baseline, 24 hours and 48 hours during fasting
Compensatory movement behaviour
During and 48 hours after the fast
- +6 more secondary outcomes
Study Arms (2)
Fasting + Exercise (FAST+EX): fasting + exercise condition
EXPERIMENTAL48-hour fast with 60 minutes of cycling on the first and second day of the fast.
Fasting only (FAST): Non-exercise fasting condition
EXPERIMENTAL48-hour fast with no structured exercise on fasting days.
Interventions
Participants will complete a 48-hour fast. One hour of exercise will be performed on each morning of the fast.
Participant will complete a 48-hour fast. No structured exercise will be performed during each of the fasting days.
Eligibility Criteria
You may qualify if:
- Aged between 19 and 35 years.
- Physically active (engaging in ≥150 minutes of weekly moderate to vigorous physical activity).
You may not qualify if:
- History of cardiometabolic diseases or inflammatory diseases (e.g., chronic obstructive pulmonary disease (COPD), rheumatoid arthritis, cardiovascular disease).
- Individuals currently following a ketogenic diet, low-calorie diet, periodic fasting regimen, or consuming ketogenic supplements (e.g., exogenous ketone drinks).
- Cigarette/vaping smoking.
- Physical limitation that will impair the ability of the participant to perform exercise.
- Individuals having a body mass index (BMI) over 30 kg/m2.
- Cancer diagnosis in the past 5 years.
- Taking anti-inflammatory drugs (e.g., ibuprofen, aspirin, naproxen).
- Being unable to read or communicate in English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of British Columbia Okanagan Campus
Kelowna, British Columbia, V1V1V7, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Jonathan Little Principal Investigator, Professor Little, Ph.D
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 8, 2024
First Posted
December 17, 2024
Study Start
January 10, 2025
Primary Completion
August 1, 2025
Study Completion
August 1, 2025
Last Updated
March 7, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared to ensure the privacy and confidentiality of participants, in accordance with ethical guidelines and data protection regulations. Additionally, this was not included in the informed consent, which did not cover data sharing or address potential risks of re-identification.